IL17A and epilepsy: In addition, previous studies have shown that IL-17 can contribute to the development of epilepsy through various pathogenic mechanisms such as neuroinflammation, breakdown of the blood-brain barrier, abnormal neurotransmitter transmission, and abnormal ion channel activity.